Does acute promyelocytic leukemia patient with the STAT5B/RARa fusion gene respond well to decitabine?: A case report and literature review

RATIONALE: Most acute promyelocytic leukemia (APL) patients respond to all-trans-retinoic acid (ATRA)and have a good prognosis. However, variants APL who carry PLZF/RARа, STAT5B/RARа, and STAT3/RARа are insensitive to ATRA and have poor prognoses. The standard treatment for variants APL is still unc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lei, Yan, Xiaojing, He, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581092/
https://www.ncbi.nlm.nih.gov/pubmed/33120845
http://dx.doi.org/10.1097/MD.0000000000022923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581092/
https://www.ncbi.nlm.nih.gov/pubmed/33120845
http://dx.doi.org/10.1097/MD.0000000000022923

Ejemplares similares